logo
Skills Canada National Competition 2025, in Regina, Wraps up with a Celebration of National Skills Champions!

Skills Canada National Competition 2025, in Regina, Wraps up with a Celebration of National Skills Champions!

Yahoo31-05-2025
Thousands of students visited the Skills Canada National Competition 2025 at the REAL District and witnessed the competitors in action
The medalists are honoured at the Skills Canada National Competition 2025, in Regina.
REGINA, Saskatchewan, May 31, 2025 (GLOBE NEWSWIRE) -- Today, Skills/Compétences Canada (SCC) released the final medal results of the Skills Canada National Competition (SCNC) 2025. Over the past week, over 500 students and apprentices from across the country competed for the title of national champion in over 40 Skill Areas at the REAL District. The complete list of medalists is available on the Skills/Compétences Canada Website. In addition, the official members of WorldSkills Team Canada 2026 were announced. They will be competing at the 48th WorldSkills Competition, in Shanghai, China, in September 2026, and will begin training for this prestigious competition.
Approximately 250 medals were awarded to the top competitors in six skilled trade and technology sectors, including: transportation, construction, manufacturing and engineering, information technology, services and employment. The competitors were evaluated based on strict industry standards and competed against the best in Canada.
During SCNC, thousands of student visitors, industry leaders, government officials and industry celebrities were in attendance to take part in the onsite activities such as the Skills Showcase featuring First Nations, Inuit and Métis Skills, the Empowering Women in the Trades initiative and over 50 Try-A-Trade® and Technology activities. Celebrities included Sherry Holmes, Contractor, TV Host and DIY Enthusiast and Arianna Dyck, Miss Rodeo Queen Agribition Alumni 2023 – 2024 and Welding Apprentice, who are both strong advocates for women in skilled trades.
The goal of SCNC is to engage Canadian youth and promote the rewarding and lucrative careers that are available to them in the skilled trades and technologies. It is the only national multi-trade and technology event of its kind for young students and apprentices in the country.
"The Skills Canada National Competition connects us with the next generation of skilled professionals, showcasing the vast opportunities in skilled trades and technologies. Through hands-on activities, students can explore exciting, in-demand career paths,' said Shaun Thorson, Chief Executive Officer, Skills/Compétences Canada.
In addition, RBC Future Launch awarded successful participants from each province and territory with a $1,500 RBC Best of Region Award at the Skills Canada National Competition. The annual award recognizes these leaders as they continue their education and training in the skilled trades industry. According to an RBC report, 'Powering Up: Preparing Canada's skilled trades for a post-pandemic economy', Canada will face a shortage of 10,000 skilled trade workers by 2026.
The Skills Canada National Competition (SCNC) is supported by our Funding Partner the Government of Canada, as well as our Presenting Sponsors, UA Canada, Cenovus Energy, Home Hardware and Regina Hotel Association. SCNC 2026 will be held at the Exhibition Place, in Toronto, Ontario, on May 28 and 29, 2026.
About Skills/Compétences CanadaSkills/Compétences Canada was founded in 1989 as a national, not‐for‐profit organization that works with employers, educators, labour groups and governments to promote skilled trade and technology careers among Canadian youth. For more information visit: www.skillscompetencescanada.com
Follow Skills/Compétences Canada on X, Facebook, YouTube, Instagram, LinkedIn and TikTok. The event hashtag is #SCNC2025.
PHOTOGRAPHY and VIDEOView the Skills/Compétences Canada Flickr page to access and upload hundreds of high resolution pictures of competitors in action.
View the highlight video of SCNC 2025.
View SCC's YouTube channel to view the livestream of the event and catch all the action. You can also access the video footage of day one and two of the competition by clicking on these links. View the cue sheets for the livestream of day one and day two.
MEDIA CONTACT: Michèle Rogerson, micheler@skillscanada.com, 613-266-4771.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/97b4defd-9f7a-4a84-9cf8-4edd330a5a1fSign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Delta Announces AGM Results
Delta Announces AGM Results

Yahoo

time23 minutes ago

  • Yahoo

Delta Announces AGM Results

Toronto, Ontario--(Newsfile Corp. - August 15, 2025) - Delta Resources Limited (TSXV: DLTA) (OTC Pink: DTARF) (FSE: 6GO1) ("Delta" or "the Company") is pleased to announce the results of voting at its Annual and Special Meeting of shareholders held on Thursday, August 14, 2025. Shareholders voted in favour of all items put forward by the Board of Directors and Management. Frank Candido, Kevin B. Heather, Justin Reid and Sara Marcotte Paquet were all re-elected as Directors of the Company and Ronald Kopas was elected as a Director of the Company. The shareholders appointed Raymond Chabot Grant Thornton LLP as auditors of the Company and approved the Company's Omnibus Equity Incentive Plan. ON BEHALF OF THE BOARD OF DELTA RESOURCES LIMITED. Frank CandidoChairman of the About Delta Resources Limited Delta Resources is a Canadian mineral exploration company focused on its Delta-1 project in Ontario, Canada, where the Company discovered a large gold deposit 50 km west of Thunder Bay, at surface and adjacent to the Trans-Canada highway. To date, the gold deposit is 2.5 km long, from surface to 300 m depth. Highlights include drill intercepts such as 5.92 g/t Au over 31 m (incl. 14.8 g/t Au over 11.9 m), and 1.79 g/t Au over 128.5 m. The property covers 297 square kilometres where Delta has identified multiple corridors of intense alteration and deformation, on strike with, and to the south of the Eureka gold zone and that has yet to be thoroughly explored. For Further Information: Contact Delta Resources Limited Frank Candido, ChairmanTel: 514-969-5530fcandido@ Kopas, CEOrkopas@ We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange has not approved nor disapproved of the information contained herein. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bank of Montreal May Sell Transport Finance Arm Amid Market Shift
Bank of Montreal May Sell Transport Finance Arm Amid Market Shift

Yahoo

timean hour ago

  • Yahoo

Bank of Montreal May Sell Transport Finance Arm Amid Market Shift

Bank of Montreal BMO is reportedly exploring the sale of its transportation finance business, which has approximately $11 billion in assets, with an estimated valuation of $1 billion. The news was first reported by Bloomberg, citing people with knowledge of the potential buyers include private equity firms and private credit players. However, no final decision has been made yet and the bank may even choose to retain the had acquired this transportation finance unit from General Electric Capital Corporation in 2015, significantly expanding its commercial vehicle lending operations across the United States and division's predictable cash flows and extensive presence in truck and trailer financing make it an attractive target in the current market, especially as traditional banks offload asset-heavy divisions and private lenders take interest.A sale can free up capital for Bank of Montreal amid macroeconomic pressures like rising interest rates, trade uncertainties (the U.S.-Canada tariffs) and increasing credit risk in the transportation sector. Recent Divestitures by Finance Firms Last month, HSBC Holdings plc HSBC agreed to sell its life insurance business in the U.K., HSBC Life (UK) Limited, to Chesnara, a life and pensions consolidator, for a cash consideration of £260 million. The completion of the deal, subject to customary regulatory approvals, is expected in early move aligns with its broader repositioning strategy to streamline operations, focusing more on markets with strong growth potential, as highlighted by CEO Georges Elhedery in October June, Huntington Bancshares HBAN announced the divestiture of the corporate trust and institutional custody business of its subsidiary, The Huntington National Bank, to Argent Institutional Trust Company to streamline its Bancshares' divestiture of its corporate trust and custody business reflects a strategic shift toward refining operations and strengthening its core banking services. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Huntington Bancshares Incorporated (HBAN) : Free Stock Analysis Report Bank Of Montreal (BMO) : Free Stock Analysis Report HSBC Holdings plc (HSBC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Merck KGaA ventures into new territory in the US
Merck KGaA ventures into new territory in the US

Yahoo

timean hour ago

  • Yahoo

Merck KGaA ventures into new territory in the US

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Merck KGaA has been making new moves to propel itself into becoming what CEO Belén Garijo described as a 'globally diversified science and technology powerhouse.' Most recently, the company closed its $3.4 billion acquisition of Pfizer spinout SpringWorks Therapeutics, which will help it stake a claim in the rare tumor space. And in general, it's all about 'doubling down' on R&D and building the company's U.S. footprint, said Miguel Fernández Alcalde, president of EMD Serono, Merck KGaA's healthcare business in the U.S. and Canada. Germany-based Merck KGaA has undergone a number of transformations throughout its deep history. In 2022, the company restructured into three distinct business units including one focused on the life sciences sector and manufacturing services. But with the contract manufacturing blitz of the COVID-19 pandemic era fading, the company is refocusing. EMD Serono relocated its U.S. headquarters to Boston's Seaport district to place itself squarely in the thick of the region's most innovative 'biotechs, startups, academia and scientists,' Fernández Alcalde said. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization." Miguel Fernández Alcalde President, EMD Serono Merck KGaA also elevated its global head of R&D and chief medical officer of its healthcare business, Dr. Danny Bar-Zohar, to healthcare CEO. 'That tells you that the company's moving along in the direction of doubling down on R&D,' Fernández Alcalde said. Fernández Alcalde's appointment to president of EMD Serono in December is also part of the company's overall quest to build its U.S. footprint and bolster R&D through external deals. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization,' he said. 'I do think we have lots of opportunities in the U.S. ecosystem and U.S. market. My job and my vision and ambition is to really untap all those things that we have ahead of us.' A pharmacist by trade, Fernández Alcalde has been with Merck KGaA since 2014, serving most recently as EMD Serono's chief operating officer. 'That gave me a lot of knowledge and understanding of the business of the company in the States and the teams, the dynamics, the culture, but also the U.S. [healthcare] ecosystem,' he said. Driving dealmaking Central to Fernández Alcalde's role is supplementing the company's current pipeline through external innovation investments, including more strategic in-licensing and co-development opportunities. The SpringWorks acquisition put the company on track to generate at least 50% of its future launch assets from external companies, compared to roughly 10%-15% just 18 months ago. 'It's easily a fivefold increase in our ambition from external innovation,' Fernández Alcalde said. In terms of what kinds of deals they're targeting, Fernández Alcalde said several factors are at play. 'We are not looking [for] the $40 billion type of acquisition,' he said. Nor will they chase first-in-class potential blockbusters with never-explored mechanisms of action. Instead, they'll target smaller deals with the 'right risk balance' for their pipeline. He pointed to the SpringWorks acquisition as an example, which not only adds two FDA-approved drugs to its portfolio, but also a 'runway of three to five years of nice growth' in the form of several clinical-phase pipeline candidates. 'These areas where we have deep, good science [and a] validated proof of concept or an about-to-be-validated proof of concept where the mechanism of action is already validated, is something we are interested in,' he said. The company will take a similar approach when it comes to therapeutic areas by branching out within reason. 'We are not sticking to the [therapeutic areas] we have today, but we are not going to go wild, either,' he said. Rather, they'll look for specialties that are 'adjacent' and 'logical' in terms of what they've been historically known for, such as oncology and neurology/immunology. Again, he pointed to the SpringWorks acquisition as an example and noted that some might ask what track record EMD Serono or Merck KGaA has in rare tumors. 'The answer is zero. But we do know how to commercialize,' he said. Plus, 'it's in an adjacent area of oncology.' Fernández Alcalde is also thinking globally, intending to follow good science wherever it leads and consider deals from around the world. 'We couldn't care less about where that science is coming from, whether it's China, my home country Spain, the U.S. or South Africa,' he said. 'If we think that science will help patients … we will definitely think about it.' Recommended Reading Let's make a deal? Big Pharma execs express varying views on their M&A future

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store